Abstract
New S-alkyl phthalimide 5a–f and S-benzyl 6a–d analogs of 5-(2-phenylquinolin-4-yl)-1,3,4-oxadiazole-2-thiol (4) were prepared by reacting 4 with N-bromoalkylphthalimide and CF3-substituted benzyl bromides in excellent yields. Spectroscopic techniques were employed to elucidate the structures of the synthesized molecules. The inhibition activity of newly synthesized molecules toward MAO-A, MAO-B, and AChE enzymes, was also assessed. All these compounds showed activity in the submicromolar range against all enzymes. Compounds 5a and 5f were found to be the most potent compounds against MAO-A (IC50 = 0.91 ± 0.15 nM) and MAO-B (IC50 = 0.84 ± 0.06 nM), while compound 5c showed the most efficient acetylcholinesterase inhibition (IC50 = 1.02± 0.65 μM). Docking predictions disclosed the docking poses of the synthesized molecules with all enzymes and demonstrated the outstanding potency of compounds 5a, 5f, and 5c (docking scores = −11.6, −15.3, and −14.0 kcal/mol against MAO-A, MAO-B, and AChE, respectively). These newly synthesized analogs act as up-and-coming candidates for the creation of safer curative use against Alzheimer’s illness.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference99 articles.
1. Author Correction: Cellular senescence and Alzheimer disease: The egg and the chicken scenario;Masliah;Nat. Rev. Neurosci.,2020
2. Alzheimer’s Disease International (2018). From Plan to Impact: Progress towards Targets of the Global Action Plan on Dementia, Alzheimer’s Disease International.
3. The Structural Hybrids of Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease: A Review;Saxena;Alzheimer’s Neurodegener. Dis.,2019
4. Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease;Yanez;Curr. Top. Med. Chem.,2013
5. New Frontiers in Selective Human MAO-B Inhibitors;Carradori;J. Med. Chem.,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献